News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AdAlta.
RELATED STOCKHEAD STORIES
Health & Biotech
CAR-T therapy is potentially a $20bn market. Here’s how it works and the ASX players in the space
Health & Biotech
ASX Health Stocks: Nanosonics jumps almost 20% as revenue momentum picks up steam
Health & Biotech
ASX health stocks today: AdAlta (ASX:1AD) leads after successful Phase I study
News
Market highlights and 5 ASX small caps to watch on Wednesday
News
ASX Small Cap Lunch Wrap: Who’s cruising for a bruising today?
Health & Biotech
AdAlta soars after getting orphan drug designation for its shark-based drug
News
10 at 10: These ASX stocks are soaring ahead this morning
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
Health & Biotech
Health Kick: Investors eye AdAlta’s fibrosis fighting i-body platform
Stockhead TV
VIDEO: 90 Seconds With…Tim Oldham, AdAlta
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
ASX Small Cap Lunchtime Wrap: Who thinks Warren Buffett is all washed up?
News
The curious case of the vanishing female executive
Health & Biotech
Adalta gets $1m in govt’s latest biotech cash splash
Tech
Tech: One of Britain’s largest tech sellers will now offer FirstWave’s cloud security tech
Health & Biotech